
NYSEHealthcareMedical - Care Facilities
أحدث البيانات المتاحة
123.33 US$
+0.79 US$ · +0.64%
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
الإغلاق السابق
123.33 US$
+0.79 US$ · +0.64%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
نطاق اليوم
السعر الحالي 123.33 US$
نطاق 52 أسبوعًا
السعر الحالي 123.33 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
84
قيمة جذابة جدًا
المشاعر
73
صعودي
المخاطر
28
مخاطر متوسطة
الزخم
50
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
نطاق اليوم
السعر الحالي 123.33 US$
نطاق 52 أسبوعًا
السعر الحالي 123.33 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 5.94 مليار USD | 5.37 مليار USD | 4.8 مليار USD | 4.35 مليار USD | 4.01 مليار USD |
| تكلفة البضاعة المباعة | 254.4 مليون USD | 3.14 مليار USD | 2.82 مليار USD | 2.6 مليار USD | 2.31 مليار USD |
| الربح الإجمالي | 5.68 مليار USD | 2.23 مليار USD | 1.98 مليار USD | 1.75 مليار USD | 1.7 مليار USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 3.41 مليار USD | 266.5 مليون USD | 258 مليون USD | 209 مليون USD | 228.5 مليون USD |
| نفقات التشغيل | 4.63 مليار USD | 1.37 مليار USD | 258 مليون USD | 1.12 مليار USD | 1.04 مليار USD |
| مصاريف الفوائد | 123.2 مليون USD | 137.4 مليون USD | 143.5 مليون USD | 175.7 مليون USD | 164.3 مليون USD |
| الاستهلاك والإطفاء | 327.9 مليون USD | 299.6 مليون USD | 273.9 مليون USD | 243.6 مليون USD | 219.6 مليون USD |
| الدخل التشغيلي | 1.05 مليار USD | 864.5 مليون USD | 1.72 مليار USD | 630.2 مليون USD | 659.4 مليون USD |
| صافي الدخل | 566.2 مليون USD | 455.7 مليون USD | 352 مليون USD | 271 مليون USD | 412.2 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
150.2 US$
ارتفاع محتمل بنسبة 21.79%| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 1 يوليو 2022 | 1,257:1,000 | — | — |
تقسيم الأسهم | 26 أكتوبر 2006 | 1:5 | — | — |
تقسيم الأسهم | 18 مارس 1997 | 2:1 | — | — |
تقسيم الأسهم | 18 أبريل 1995 | 2:1 | — | — |
تقسيم الأسهم | 2 يناير 1992 | 3:2 | — | — |
ساري 1 يوليو 2022
1,257:1,000
ساري 26 أكتوبر 2006
1:5
ساري 18 مارس 1997
2:1
ساري 18 أبريل 1995
2:1
ساري 2 يناير 1992
3:2
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI379.52 مليون0.02%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard Morningstar Small-Cap ETFVB274.28 مليون0.15%185.3 مليار USD0.03%289.48 US$+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR174.25 مليون0.25%68.2 مليار USD0.05%234.43 US$+0.22%
Vanguard Extended Market ETFVXF138.52 مليون0.14%95.4 مليار USD0.05%235 US$+0.80%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY89.82 مليون0.35%25.58 مليار USD0.23%669.87 US$+0.54%
iShares S&P Mid-Cap 400 Growth ETFIJK72.45 مليون0.68%10.69 مليار USD0.16%112.03 US$+1.02%
Dimensional - US Small Cap ETFDFAS69.31 مليون0.21%33.87 مليار USD0.31%78.35 US$+0.32%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD64.68 مليون0.35%18.27 مليار USD0.03%64.33 US$+0.56%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
State Street SPDR S&P MIDCAP 400 ETF TrustMDY
iShares S&P Mid-Cap 400 Growth ETFIJK
Dimensional - US Small Cap ETFDFAS
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMDالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.